Hyderabad: Hyderabad-based Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), appointed Sauri Gudlavalleti as its chief operating officer. Sauri will report to the CEO & managing director, Krishna Kanumuri and drive the company’s growth as a new generation, science-driven organisation. Making the announcement, Krishna Kanumuri said, “Sauri Gudlavalleti brings with him […]
This investment is a part of an organisational transformation initiative (Sai Nxt), where the company is investing $150 million (over Rs 1,000 crore) in the period between 2019 and 2023
